We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pacific Northwest Udall Center (PANUC) Clinical Core (PANUC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01720810
Recruitment Status : Recruiting
First Posted : November 2, 2012
Last Update Posted : May 31, 2017
Information provided by (Responsible Party):
Cyrus Zabetian, University of Washington

Brief Summary:
This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the natural history, diagnosis and ultimate treatment of cognitive impairment in patients with PD and similar disorders.

Condition or disease
Parkinson Disease Cognitive Impairment

Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Pacific Northwest Udall Center (PANUC) Clinical Core
Study Start Date : March 2010
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2020

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All subjects undergo the following procedures:

  • Interview to collect data on medical history and demographics
  • Neurological examination
  • Questionnaires about mood, activities of daily living, and environmental exposures.
  • Psychometric tests

Study companions might also be asked to complete questionnaires about the participant's thinking and memory, activities of daily living, sleep, and neuropsychiatric symptoms.


Inclusion Criteria:

  • Diagnosis of Parkinson disease
  • Over 18 years of age

Exclusion Criteria:

- Under 18 years of age

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01720810

Contact: Louren Reed (206) 277-5516 louren@uw.edu

United States, Washington
VA Puget Sound Health Care System Recruiting
Seattle, Washington, United States, 98108
Contact: Louren Reed    206-277-5516    louren@uw.edu   
Principal Investigator: Cyrus P Zabetian, MD, MS         
Sponsors and Collaborators
University of Washington

Responsible Party: Cyrus Zabetian, Associate Professor, Neurology, University of Washington
ClinicalTrials.gov Identifier: NCT01720810     History of Changes
Other Study ID Numbers: 37855
First Posted: November 2, 2012    Key Record Dates
Last Update Posted: May 31, 2017
Last Verified: May 2017

Additional relevant MeSH terms:
Parkinson Disease
Cognitive Dysfunction
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Cognition Disorders
Neurocognitive Disorders
Mental Disorders